USA – FDA drafts guidance on essential outputs for drug delivery devices

The US Food and Drug Administration (FDA) has issued a draft guidance to assist sponsors of drug-device combination products in developing “essential drug delivery...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical devices: UK approved bodies

Approved bodies under Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) for medical devices...

Europe – MDCG 2021-5 Rev. 1 : Guidance on standardisation for medical devices

The EU legislative framework on medical devices currently consists of two Regulations adopted and entered into force in 2017: • Regulation (EU) 2017/745 on medical...

USA – Essential Drug Delivery Outputs for Devices Intended to Deliver Drugs and Biological...

This guidance addresses key aspects of drug delivery performance information for devices, and combination products that include device constituent parts, intended for delivery of...

Europe – MDCG 2024-10 Clinical evaluation of orphan medical devices

The level of clinical evidence that is required to place medical devices on the market has been increased by the MDR, including an increased...
La Suisse valide l'utilisation du cannabis à des fins médicales

Switzerland – Swissmedic prepares medtech industry for activation of medical devices database module

The first module of the swissdamed medical devices database goes online in August Since the MRA with the EU has not been updated, Swissmedic does...

Europe – Health Technology Assessment : Guidance on reporting requirements for multiplicity issues and...

This guidance describes how to deal in practice with multiplicity issues and complementary analyses (like specific subgroup analyses, specific post hoc analyses and sensitivity analyses)...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Health Technology Assessment : Guidance on outcomes for joint clinical assessments

Clinical outcome assessments (COAs), used in clinical studies (whether they are interventional (also called experimental), or observational), are a key component of health technology...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – Phthalates in certain medical devices: updated SCHEER guidelines published

Today, following a request from the European Commission, the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) provided the update of their guidelines on...
TGA Updates Guidance on the Testing of Biological Medicines

Australia – Medical device regulation changes

Changes have been made to the regulation of: software-based medical devices prescription spectacle lenses medical devices containing microbial, recombinant, or animal substances medical device...

NOS PROCHAINES FORMATIONS